European Biotech Acquisition Corp.
NASDAQ: EBAC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Financial Services
- Industry
- Shell Companies
- CEO
- Eduardo Bravo Fernandez de Araoz
- Headquarters
- Amsterdam, Netherlands
- IPO year
- 2021
- Market cap
- $183.5M
- Website
- https://www.lspvc.com/ebac
Loading EBAC…
Loading profile data…Frequently asked questions about EBAC
What does European Biotech Acquisition Corp. (EBAC) do?
European Biotech Acquisition Corp. (EBAC) is presently not engaged in substantial business operations. Instead, its core purpose is to facilitate a business combination, potentially through a merger, share exchange, asset acquisition, share purchase, or reorganization, with one or more other companies or organizations. The firm was established i...
Where does EBAC trade?
European Biotech Acquisition Corp. (EBAC) trades on the NASDAQ Capital Market.
What sector is EBAC in?
European Biotech Acquisition Corp. (EBAC) operates in the Financial Services sector, specifically in the Shell Companies industry.
Who is the CEO of European Biotech Acquisition Corp.?
Eduardo Bravo Fernandez de Araoz is the chief executive officer of European Biotech Acquisition Corp. (EBAC).
Where is European Biotech Acquisition Corp. headquartered?
European Biotech Acquisition Corp. is headquartered in Netherlands.
Does EBAC pay a dividend?
European Biotech Acquisition Corp. (EBAC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did EBAC go public?
European Biotech Acquisition Corp. (EBAC) completed its initial public offering in 2021.